ArticlePediatric pulmonology2026
"No Words for Feelings": Alexithymia in Children With Cystic Fibrosis and Their Caregivers.
Article in Pediatric pulmonology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- "No Words for Feelings": Alexithymia in Children With Cystic Fibrosis and Their Caregivers.Pediatric pulmonology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimChildren with cystic fibrosis (CF) face significant physical and psychological challenges due to their chronic condition, which may affect emotional regulation and sleep quality. Alexithymia, characterized by difficulties in identifying and expressing emotions, has been linked to psychological distress and poor health outcomes in chronic illnesses. However, its prevalence and impact on CF patients and their caregivers remain underexplored. This study investigates alexithymia in children with CF and their mothers, examining its association with sleep disorders and depression.
methodsThis cross-sectional study included 36 children with CF aged 9-18 years and their mothers. Emotional regulation was assessed using the Toronto Alexithymia Scale (TAS-20) for both groups. Sleep quality in children was evaluated by Sleep Disturbance Scale for Children (SDSC), and maternal depression was assessed using the Beck Depression Scale (BDS). Clinical parameters, including pulmonary function tests (PFTs), modified Shwachman-Kulczycki (mSK), and BMI z-scores, were analyzed for correlations with alexithymia.
resultsAlexithymia was prevalent in 58.3% of children and 55.6% of mothers. Higher TAS-20 scores in children correlated with worse SDSC scores (r = 0.55, p < 0.001), indicating significant sleep disturbances. Maternal TAS-20 scores correlated with BDS scores (r = 0.61, p < 0.001), reflecting a strong association with depression. No significant correlations were observed between TAS-20 scores and clinical parameters.
conclusionAlexithymia is prevalent among children with CF and their mothers, contributing to poor sleep in children and maternal depression. Routine psychological screening for emotional regulation difficulties in both patients and caregivers may enhance the quality of CF care and improve emotional and clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.